Video | The Medical Cannabis and Wellness ETF PM says GW Pharma deal validates pharmaceutical cannabinoids
Watch Nawan Butt, portfolio manager at Purpose Investments and co-founder of the Medical Cannabis and Wellness UCITS ETF discuss the acquisition of GW Pharma by Jazz Pharmaceuticals. GW Pharma is one of the largest holdings in our medical cannabis ETF and is welcomed by investors as it opens the space for medical cannabis to enter the traditional pharmaceutical space.